Price
Financials
Standalone, Rs crore| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 107 | 139 | 126 | 139 | 139 | 210 |
| Expenses | 87 | 119 | 107 | 115 | 115 | 177 |
| Operating Profit | 20 | 20 | 19 | 23 | 24 | 33 |
| OPM % | 18% | 14% | 15% | 17% | 17% | 16% |
| Other Income | 1 | 2 | 3 | 3 | 3 | 4 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 3 |
| Profit before tax | 17 | 19 | 20 | 24 | 24 | 34 |
| Tax % | 18% | 17% | 16% | 32% | 25% | 25% |
| Net Profit | 14 | 16 | 16 | 17 | 18 | 26 |
| EPS in Rs | 8.01 | 6.70 | 6.86 | 6.92 | 7.53 | 10.75 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 114 | 131 | 133 | 166 | 197 | 246 | 265 | 349 |
| Expenses | 108 | 122 | 122 | 153 | 178 | 206 | 223 | 292 |
| Operating Profit | 6 | 9 | 11 | 13 | 19 | 39 | 42 | 57 |
| OPM % | 4.9% | 7% | 8% | 8% | 10% | 16% | 16% | 16% |
| Other Income | 6 | 4 | 2 | 2 | 2 | 3 | 6 | 7 |
| Interest | 3 | 3 | 3 | 3 | 3 | 1 | 0 | 1 |
| Depreciation | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 |
| Profit before tax | 5 | 6 | 6 | 8 | 15 | 37 | 44 | 58 |
| Tax % | 24% | 31% | 20% | 22% | 17% | 17% | 24% | 25% |
| Net Profit | 4 | 4 | 5 | 6 | 12 | 30 | 33 | 44 |
| EPS in Rs | 7.39 | 8.53 | 9.80 | 4.01 | 8.26 | 12.57 | 13.78 | 18.28 |
| Dividend Payout % | 0% | 0% | 9% | 18% | 8% | 7% | 6% | 5% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 21% | 21% | 32% | ||
| Compounded Profit Growth | % | 54% | 53% | 33% | ||
| Stock Price CAGR | % | % | % | 177% | ||
| Return on Equity | % | 21% | 21% | 19% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 13 | 13 | 21 | 21 | 24 |
| Reserves | 17 | 21 | 22 | 19 | 37 | 143 | 174 | 252 |
| Borrowings | 32 | 30 | 31 | 24 | 23 | 13 | 2 | 1 |
| Other Liabilities | 20 | 22 | 23 | 38 | 37 | 28 | 32 | 45 |
| Total Liabilities | 73 | 77 | 81 | 95 | 111 | 205 | 228 | 322 |
| Fixed Assets | 30 | 29 | 30 | 30 | 31 | 29 | 48 | 53 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 2 | 13 | 102 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 43 | 48 | 50 | 64 | 79 | 174 | 168 | 167 |
| Total Assets | 73 | 77 | 81 | 95 | 111 | 205 | 228 | 322 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 6 | 5 | 5 | 15 | 8 | 11 | 25 | 19 |
| Cash from Investing Activity | -4 | -2 | -6 | -4 | -4 | -82 | -9 | -49 |
| Cash from Financing Activity | -1 | -2 | -2 | -10 | -4 | 72 | -14 | 36 |
| Net Cash Flow | 1 | 1 | -3 | 1 | -1 | 1 | 2 | 6 |
| Free Cash Flow | 2 | 3 | -0 | 11 | 3 | -2 | -12 | -68 |
| CFO/OP | 120% | 72% | 57% | 127% | 53% | 44% | 85% | 56% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 70 | 60 | 35 | 38 | 56 | 80 | 89 | 95 |
| Inventory Days | 67 | 78 | 128 | 128 | 128 | 83 | 76 | 55 |
| Days Payable | 89 | 80 | 74 | 97 | 106 | 48 | 42 | 33 |
| Cash Conversion Cycle | 48 | 58 | 88 | 68 | 79 | 114 | 124 | 117 |
| Working Capital Days | 19 | 30 | 37 | 16 | 41 | 79 | 101 | 95 |
| ROCE % | 18% | 17% | 19% | 27% | 31% | 24% | 25% |
| Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Promoters | 55.09% | 55.09% | 55.09% | 55.09% | 55.44% | 55.44% | 55.47% | 53.02% |
| FIIs | 0.03% | 0.02% | 0.01% | 0.01% | 0.00% | 0.29% | 0.58% | 0.91% |
| DIIs | 1.62% | 1.66% | 2.19% | 2.88% | 3.29% | 3.57% | 3.59% | 3.54% |
| Public | 43.26% | 43.23% | 42.70% | 42.01% | 41.27% | 40.70% | 40.36% | 42.53% |
| No. of Shareholders | 2,418 | 2,999 | 2,834 | 2,982 | 3,061 | 3,076 | 3,054 | 3,178 |
Fundamentals
Market Cap₹ 1,617 Cr.
Current Price₹ 674
Stock P/E36.9
Book Value₹ 115
ROCE24.9 %
ROE18.6 %
Dividend Yield0.15 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)32%
Compounded Profit Growth (TTM)33%
Standalone figures.
Valuation
Market capRs 1,410 Cr
Enterprise valueRs 1,350 Cr
P/E (TTM)46.72x
Price to book8.60x
Price to sales5.74x
EV / EBITDA32.06x
EV / EBIT35.83x
EV / sales5.50x
Price to cash flow124.42x
Earnings yield2.14%
Dividend yield0.15%
P/E, 3-year average16.21x
P/B, 3-year average2.99x
P/E, 5-year average16.21x
P/B, 5-year average2.99x
Profitability
Operating margin (excl. other income)16.08%
Operating margin (incl. other income)17.15%
EBITDA margin17.15%
Pre-tax margin14.88%
Net profit margin12.29%
ROE28.16%
ROCE30.16%
ROA19.12%
ROE, 3-year average25.96%
ROCE, 3-year average25.24%
ROA, 3-year average12.59%
ROE, 5-year average22.92%
ROCE, 5-year average22.02%
ROA, 5-year average9.89%
ROIC (approx.)29.89%
Tax rate17.41%
Other income / net worth1.61%
Growth
Sales growth (latest year)24.45%
Profit growth (latest year)146.69%
Sales CAGR, 3 years22.80%
Sales CAGR, 5 years16.59%
Profit CAGR, 3 years84.55%
Profit CAGR, 5 years52.82%
Per share
EPS (TTM)Rs 14.34
EPS (latest year)Rs 14.34
EPS, 3-year averageRs 9.45
EPS, 5-year averageRs 9.85
Book value per shareRs 77.85
Sales per shareRs 116.67
Cash flow per shareRs 5.38
Free cash flow per shareRs -32.31
Dividend per share (latest year)Rs 1.00
Dividend per share, 3-year averageRs 0.87
Dividend per share, 5-year averageRs 0.90
Dividends
Dividend payout6.96%
Dividend payout, 3-year average10.98%
Dividend payout, 5-year average10.48%
Efficiency
Asset turnover1.20x
Fixed asset turnover8.45x
Inventory turnover5.39x
Inventory days68 days
Debtor days80 days
Debtors turnover4.56x
Creditor days33 days
Cash conversion cycle117 days
Working capital days95 days
Leverage
Total debtRs 13 Cr
Cash and bankRs 72 Cr
Net debtRs -60 Cr
Debt to equity0.08x
Net debt / EBITDA-1.42x
Interest coverage32.77x
Owners' fund to total sources79.98%
Debt to assets6.24%
Cash flow
Cash from Operating Activity (latest year)Rs 11 Cr
Cash from Investing Activity (latest year)Rs -82 Cr
Cash from Financing Activity (latest year)Rs 72 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -68 Cr
FCFE (approx.: FCF + change in debt)Rs -78 Cr
Cash from ops / profit, 5 years0.62x
Sales to cash flow21.67x
Statement figures
Net sales (TTM)Rs 246 Cr
Net sales (latest year)Rs 246 Cr
Operating profit excl. other income (latest year)Rs 39 Cr
Other income (TTM)Rs 3 Cr
EBITDA (TTM)Rs 42 Cr
PBDT (TTM)Rs 41 Cr
Profit before tax (TTM)Rs 37 Cr
Tax (latest year)Rs 6 Cr
Net profit (TTM)Rs 30 Cr
Net profit (latest year)Rs 30 Cr
Depreciation (TTM)Rs 4 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 178 Cr
Total expenditure (latest year)Rs 206 Cr
Total income (latest year)Rs 248 Cr
Share capitalRs 21 Cr
ReservesRs 143 Cr
Shareholders' fundsRs 164 Cr
Total assetsRs 205 Cr
Net blockRs 29 Cr
Capital work in progressRs 2 Cr
ReceivablesRs 54 Cr
InventoryRs 33 Cr
Other liabilitiesRs 28 Cr
Shares outstanding (crore)2.10
Ownership
Promoter holding53.02% (-2.07 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 46.7 is at the 14th percentile of its own 2.9-year range
(median 76.0, low 33.9, high 128.2).
P/B 8.60 is at the 9th percentile (median 14.83).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | ACCENTMIC | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -0.6% | -2.8% | +2.1 pts |
| 1 month | +10.6% | -6.8% | +17.4 pts |
| 3 months | +34.2% | -7.6% | +41.8 pts |
| 6 months | +88.6% | +0.4% | +88.2 pts |
| 1 year | +168.3% | -9.9% | +178.2 pts |
| 2 years | +146.7% | -13.6% | +160.3 pts |
Red flags
F-score 5 of 8| explain | Receivables outrunning sales Receivables grew 77% vs sales +24% in 2026 |
| look | Share dilution Share count up 62% in a year |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹210 Cr +51.1% vs Mar 2024.
Net profit ₹26 Cr +62.5%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Close to Close price movement greater than 100perc in previous 365 daysClose to Close price movement greater than 75perc in previous 6 monthsHigh low price variation greater than 100perc in previous 6 monthsLess than 100 unique PAN traded in previous 30 daysSME scrip is not regularly traded
Quick answers
What is the market cap of Accent Microcell Ltd?
Accent Microcell Ltd (ACCENTMIC) has a market capitalisation of Rs 1,617 Cr. at the 2026-10-01 close.
What is the P/E ratio of Accent Microcell Ltd?
Accent Microcell Ltd trades at a P/E of 36.9 on trailing twelve-month profit, at the 2026-10-01 close.
What were Accent Microcell Ltd's latest quarterly results?
In the Mar 2026 quarter, Accent Microcell Ltd sales was Rs 210 Cr (+51.1% vs Mar 2024) and net profit was Rs 26 Cr.
What is the 52-week high and low of Accent Microcell Ltd?
The 52-week high is Rs 731.70 and the 52-week low is Rs 238.00.